SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-14-072258
Filing Date
2014-10-17
Accepted
2014-10-17 16:30:10
Documents
1
Period of Report
2014-10-16

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3005
  Complete submission text file 0001104659-14-072258.txt   4426
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address THERAVANCE, INC. 951 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
dEsparbes Eric (Reporting) CIK: 0001622268 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30319 | Film No.: 141162152